Corcept Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCorcept Therapeutics
Corcept Therapeutics logo

Corcept Therapeutics

0 followers

CORT

Performance

About Corcept Therapeutics

Corcept Therapeutics advances cortisol modulation therapies focused on treating serious diseases by targeting the glucocorticoid receptor. The company conducts research and clinical development across endocrinology, oncology, metabolism, and neurology, aiming to unlock the therapeutic potential of cortisol modulation. Based in the United States, it communicates a commitment to scientific innovation and patient health through its pipeline and scientific publications.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Charles Robb

Chief Business Officer

Roberto Vieira

President, Oncology

William Guyer, PharmD

Chief Development Officer

Hazel Hunt, Ph.D.

Chief Scientific Officer

Joseph Belanoff, M.D.

Chief Executive Officer, President and Director

Key Facts

HQ Location

Redwood City, United States

Founded

1998

Employees

501-1K

Status

Public

Website

https://corcept.com